331 related articles for article (PubMed ID: 11990078)
1. Amphetamine-induced enhancement of neostriatal in vivo microdialysate dopamine content in rats, quinpirole-primed as neonates.
Nowak P; Brus R; Kostrzewa RM
Pol J Pharmacol; 2001; 53(4):319-29. PubMed ID: 11990078
[TBL] [Abstract][Full Text] [Related]
2. Prenatal cadmium and ethanol increase amphetamine-evoked dopamine release in rat striatum.
Nowak P; Dabrowska J; Bortel A; Izabela B; Kostrzewa RM; Brus R
Neurotoxicol Teratol; 2006; 28(5):563-72. PubMed ID: 17005368
[TBL] [Abstract][Full Text] [Related]
3. DSP-4 prevents dopamine receptor priming by quinpirole.
Nowak P; Labus Ł; Kostrzewa RM; Brus R
Pharmacol Biochem Behav; 2006 May; 84(1):3-7. PubMed ID: 16675001
[TBL] [Abstract][Full Text] [Related]
4. The effects of adulthood nicotine treatment on D2-mediated behavior and neurotrophins of rats neonatally treated with quinpirole.
Brown RW; Perna MK; Schaefer TL; Williams MT
Synapse; 2006 Apr; 59(5):253-9. PubMed ID: 16408261
[TBL] [Abstract][Full Text] [Related]
5. Behavioral sensitization to quinpirole is not associated with increased nucleus accumbens dopamine overflow.
Koeltzow TE; Austin JD; Vezina P
Neuropharmacology; 2003 Jan; 44(1):102-10. PubMed ID: 12559127
[TBL] [Abstract][Full Text] [Related]
6. Adolescent nicotine sensitization and effects of nicotine on accumbal dopamine release in a rodent model of increased dopamine D2 receptor sensitivity.
Perna MK; Brown RW
Behav Brain Res; 2013 Apr; 242():102-9. PubMed ID: 23291224
[TBL] [Abstract][Full Text] [Related]
7. 7-Nitroindazole enhances amphetamine-evoked dopamine release in rat striatum. an in vivo microdialysis and voltammetric study.
Nowak P; Brus R; Oświecimska J; Sokoła A; Kostrzewa RM
J Physiol Pharmacol; 2002 Jun; 53(2):251-63. PubMed ID: 12120900
[TBL] [Abstract][Full Text] [Related]
8. Neonatal quinpirole treatment enhances locomotor activation and dopamine release in the nucleus accumbens core in response to amphetamine treatment in adulthood.
Cope ZA; Huggins KN; Sheppard AB; Noel DM; Roane DS; Brown RW
Synapse; 2010 Apr; 64(4):289-300. PubMed ID: 19953655
[TBL] [Abstract][Full Text] [Related]
9. Effect of ketanserin and amphetamine on nigrostriatal neurotransmission and reactive oxygen species in Parkinsonian rats. In vivo microdialysis study.
Nowak P; Szczerbak G; Biedka I; Drosik M; Kostrzewa RM; Brus R
J Physiol Pharmacol; 2006 Dec; 57(4):583-97. PubMed ID: 17229983
[TBL] [Abstract][Full Text] [Related]
10. Ontogenetic quinpirole treatment produces long-lasting decreases in the expression of Rgs9, but increases Rgs17 in the striatum, nucleus accumbens and frontal cortex.
Maple AM; Perna MK; Parlaman JP; Stanwood GD; Brown RW
Eur J Neurosci; 2007 Nov; 26(9):2532-8. PubMed ID: 17970732
[TBL] [Abstract][Full Text] [Related]
11. Co-release of noradrenaline and dopamine in the prefrontal cortex after acute morphine and during morphine withdrawal.
Devoto P; Flore G; Pira L; Diana M; Gessa GL
Psychopharmacology (Berl); 2002 Mar; 160(2):220-4. PubMed ID: 11875641
[TBL] [Abstract][Full Text] [Related]
12. Modulation of pre- and postsynaptic dopamine D2 receptor function by the selective kappa-opioid receptor agonist U69593.
Acri JB; Thompson AC; Shippenberg T
Synapse; 2001 Mar; 39(4):343-50. PubMed ID: 11169785
[TBL] [Abstract][Full Text] [Related]
13. Ontogenetic quinpirole treatments fail to prime for D2 agonist-enhancement of locomotor activity in 6-hydroxydopamine-lesioned rats.
Brus R; Kostrzewa RM; Nowak P; Perry KW; Kostrzewa JP
Neurotox Res; 2003; 5(5):329-38. PubMed ID: 14715452
[TBL] [Abstract][Full Text] [Related]
14. Effects of Ningdong granule on the dopamine system of Tourette's syndrome rat models.
Lv H; Li A; Ma H; Liu F; Xu H
J Ethnopharmacol; 2009 Jul; 124(3):488-92. PubMed ID: 19467315
[TBL] [Abstract][Full Text] [Related]
15. Pergolide potentiates L-DOPA-induced dopamine release in rat striatum after lesioning with 6-hydroxydopamine.
Dethy S; Laute MA; Damhaut P; Goldman S
J Neural Transm (Vienna); 1999; 106(2):145-58. PubMed ID: 10226935
[TBL] [Abstract][Full Text] [Related]
16. Effect of AdGDNF on dopaminergic neurotransmission in the striatum of 6-OHDA-treated rats.
Smith AD; Kozlowski DA; Bohn MC; Zigmond MJ
Exp Neurol; 2005 Jun; 193(2):420-6. PubMed ID: 15869944
[TBL] [Abstract][Full Text] [Related]
17. Characterization of interactions between phencyclidine and amphetamine in rodent prefrontal cortex and striatum: implications in NMDA/glycine-site-mediated dopaminergic dysregulation and dopamine transporter function.
Sershen H; Balla A; Aspromonte JM; Xie S; Cooper TB; Javitt DC
Neurochem Int; 2008 Jan; 52(1-2):119-29. PubMed ID: 17716783
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding.
Parker EM; Cubeddu LX
J Pharmacol Exp Ther; 1988 Apr; 245(1):199-210. PubMed ID: 3129549
[TBL] [Abstract][Full Text] [Related]
19. Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization.
Wolf ME; White FJ; Nassar R; Brooderson RJ; Khansa MR
J Pharmacol Exp Ther; 1993 Jan; 264(1):249-55. PubMed ID: 8093727
[TBL] [Abstract][Full Text] [Related]
20. Dissociation of the effects of amphetamine and quinpirole on dopamine release in the nucleus accumbens following behavioural sensitization: an ex vivo voltammetric study.
Muscat R; Patel J; Trout SJ; Wieczorek W; Kruk ZL
Behav Pharmacol; 1993; 4(4):411-418. PubMed ID: 11224210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
